Provided by Tiger Trade Technology Pte. Ltd.

CSPC PHARMA

9.285
-0.530-5.40%
Volume:92.21M
Turnover:878.44M
Market Cap:106.98B
PE:23.34
High:10.040
Open:9.880
Low:9.235
Close:9.815
52wk High:10.720
52wk Low:6.387
Shares:11.52B
HK Float Shares:11.52B
Volume Ratio:1.56
T/O Rate:0.80%
Dividend:0.34
Dividend Rate:3.64%
EPS(LYR):0.398
ROE:20.90%
ROA:10.70%
PB:2.43
PE(LYR):23.34
PS:2.92

Loading ...

Movement Alert|CSPC PHARMA Rises 3.19% in Regular Trading, Monkeypox mRNA Vaccine Receives FDA Clinical Trial Approval

Market Focus
·
Aug 11

CSPC Pharmaceutical's Mpox Vaccine Candidate Gets Trial Approval from US FDA

MT Newswires Live
·
Aug 10

CSPC Pharma Sets 20 Aug 2026 Board Meeting to Approve 1H 2026 Interim Results

Bulletin Express
·
Aug 10

CSPC Pharma (01093) Receives FDA Clearance for US Clinical Trial of Monkeypox mRNA Vaccine

Stock News
·
Aug 10

CSPC Says FDA Clears US Clinical Trial for SYS 6037 Mpox mRNA Vaccine

Reuters
·
Aug 10

CSPC Pharmaceutical - Sys6037 Mpox Mrna Vaccine Obtains FDA Clinical Trial Approval in U.S.

THOMSON REUTERS
·
Aug 10

Movement Alert|CSPC PHARMA Rises 4.43% in Regular Trading, AstraZeneca Collaboration Deepens with Milestone Payment and Joint Venture

Market Focus
·
Aug 10

CSPC Pharmaceutical Group Stock Advances 1.5% in Hong Kong, Outperforms Competitors

Dow Jones
·
Aug 06

Hong Kong Stock Exchange News Highlights: Beone Medicines Sees 111% Surge in Adjusted Net Profit for First Half of the Year

Stock News
·
Aug 06

CSPC Pharma Secures US$10.00 million Milestone Payment from AstraZeneca under Small-Molecule R&D Pact

Bulletin Express
·
Aug 05

CSPC Pharmaceutical Receives USD 10 Million AstraZeneca Milestone Payment Under Research Pact

Reuters
·
Aug 05

CSPC Pharma and AstraZeneca to Establish 51/49 Joint Venture for Next-Generation Biologics Facility in Shijiazhuang

Bulletin Express
·
Aug 05

CSPC Pharmaceutical and AstraZeneca Enter JV for Biologics Facility in China

Reuters
·
Aug 05

CSPC Pharmaceutical Group Stock Falls 1.3% in Hong Kong, Underperforms Competitors

Dow Jones
·
Aug 05

CSPC Pharma, AstraZeneca Form Biologics Manufacturing JV in China with 51%-49% Split

Reuters
·
Aug 05

CSPC Pharmaceutical - Co to Hold 51% and AstraZeneca 49% in Joint Venture

THOMSON REUTERS
·
Aug 05

CSPC Pharmaceutical - Joint Venture to Manufacture Biologics Drug Substances for Global Markets

THOMSON REUTERS
·
Aug 05

CSPC Pharma Unit, Alphamab Oncology's Breast Cancer Drug Application Granted Priority Review in China

MT Newswires Live
·
Aug 04

CSPC Says NMPA Accepts NDA for Anbenitamab, Albumin-Bound Docetaxel Neoadjuvant Breast Cancer Combo Under Priority Review

Reuters
·
Aug 04

Alphamab Oncology Says NMPA Accepts NDA for Anbenitamab (kn026)

Reuters
·
Aug 04